179 related articles for article (PubMed ID: 9115983)
1. Interaction of urokinase-type plasminogen activator with its receptor rapidly induces activation of glucose transporters.
Anichini E; Zamperini A; Chevanne M; Caldini R; Pucci M; Fibbi G; Del Rosso M
Biochemistry; 1997 Mar; 36(11):3076-83. PubMed ID: 9115983
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-dependent angiogenesis in vitro and diacylglycerol production are blocked by antisense oligonucleotides against the urokinase receptor.
Fibbi G; Caldini R; Chevanne M; Pucci M; Schiavone N; Morbidelli L; Parenti A; Granger HJ; Del Rosso M; Ziche M
Lab Invest; 1998 Sep; 78(9):1109-19. PubMed ID: 9759655
[TBL] [Abstract][Full Text] [Related]
3. Production of second messengers following chemotactic and mitogenic urokinase-receptor interaction in human fibroblasts and mouse fibroblasts transfected with human urokinase receptor.
Anichini E; Fibbi G; Pucci M; Caldini R; Chevanne M; Del Rosso M
Exp Cell Res; 1994 Aug; 213(2):438-48. PubMed ID: 8050501
[TBL] [Abstract][Full Text] [Related]
4. Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.
Tabengwa EM; Grenett HE; Benza RL; Abou-Agag LH; Tresnak JK; Wheeler CG; Booyse FM
Alcohol Clin Exp Res; 2001 Feb; 25(2):163-70. PubMed ID: 11236828
[TBL] [Abstract][Full Text] [Related]
5. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-urokinase receptor interaction: non-mitogenic signal transduction in human epidermal cells.
Del Rosso M; Anichini E; Pedersen N; Blasi F; Fibbi G; Pucci M; Ruggiero M
Biochem Biophys Res Commun; 1993 Jan; 190(2):347-52. PubMed ID: 8381273
[TBL] [Abstract][Full Text] [Related]
7. Reversion of the invasive phenotype of transformed human fibroblasts by anti-messenger oligonucleotide inhibition of urokinase receptor gene expression.
Quattrone A; Fibbi G; Anichini E; Pucci M; Zamperini A; Capaccioli S; Del Rosso M
Cancer Res; 1995 Jan; 55(1):90-5. PubMed ID: 7805047
[TBL] [Abstract][Full Text] [Related]
8. Urokinase (u-PA) is produced by collecting duct principal cells and is post-transcriptionally regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.
Piedagnel R; Tiger Y; Lelongt B; Ronco PM
J Cell Physiol; 2006 Feb; 206(2):394-401. PubMed ID: 16155905
[TBL] [Abstract][Full Text] [Related]
9. Thrombin increases expression of urokinase receptor by activation of the thrombin receptor.
Yang Z; Cohen RL; Lui GM; Lawrence DA; Shuman MA
Invest Ophthalmol Vis Sci; 1995 Oct; 36(11):2254-61. PubMed ID: 7558719
[TBL] [Abstract][Full Text] [Related]
10. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
Hasegawa T; Sorensen L; Dohi M; Rao NV; Hoidal JR; Marshall BC
Am J Respir Cell Mol Biol; 1997 Jun; 16(6):683-92. PubMed ID: 9191470
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
12. Receptor-mediated regulation of plasminogen activator function: plasminogen activation by two directly membrane-anchored forms of urokinase.
Vines DJ; Lee SW; Dichek DA; Ellis V
J Pept Sci; 2000 Sep; 6(9):432-9. PubMed ID: 11016879
[TBL] [Abstract][Full Text] [Related]
13. The urokinase receptor and cell migration.
Blasi F
Semin Thromb Hemost; 1996; 22(6):513-6. PubMed ID: 9122717
[TBL] [Abstract][Full Text] [Related]
14. Binding of human single chain urokinase to Chinese Hamster Ovary cells and cloning of hamster u-PAR.
Fowler B; Mackman N; Parmer RJ; Miles LA
Thromb Haemost; 1998 Jul; 80(1):148-54. PubMed ID: 9684801
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
[TBL] [Abstract][Full Text] [Related]
16. Functions of the fibrinolytic system in human Ito cells and its control by basic fibroblast and platelet-derived growth factor.
Fibbi G; Pucci M; Grappone C; Pellegrini G; Salzano R; Casini A; Milani S; Del Rosso M
Hepatology; 1999 Mar; 29(3):868-78. PubMed ID: 10051491
[TBL] [Abstract][Full Text] [Related]
17. ANG II increases 2-deoxyglucose uptake in mouse embryonic stem cells.
Han HJ; Heo JS; Lee YJ
Life Sci; 2005 Aug; 77(15):1916-33. PubMed ID: 15946695
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of protein synthesis cause increased hexose transport in cultured human fibroblasts by a mechanism other than transporter translocation.
Germinario RJ; Manuel S; Chang Z; Leckett B
J Cell Physiol; 1992 Apr; 151(1):156-63. PubMed ID: 1560041
[TBL] [Abstract][Full Text] [Related]
19. Receptors for plasminogen activator, urokinase, in normal and Rous sarcoma virus-transformed mouse fibroblasts.
Del Rosso M; Dini G; Fibbi G
Cancer Res; 1985 Feb; 45(2):630-6. PubMed ID: 2981611
[TBL] [Abstract][Full Text] [Related]
20. Malignant transformation of human fibroblasts correlates with increased activity of receptor-bound plasminogen activator.
Jankun J; Maher VM; McCormick JJ
Cancer Res; 1991 Feb; 51(4):1221-6. PubMed ID: 1847659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
